195 related articles for article (PubMed ID: 19536331)
1. Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling.
Bheda A; Yue W; Gullapalli A; Whitehurst C; Liu R; Pagano JS; Shackelford J
PLoS One; 2009 Jun; 4(6):e5955. PubMed ID: 19536331
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin C-terminal hydrolase-L1 interacts with adhesion complexes and promotes cell migration, survival, and anchorage independent growth.
Frisan T; Coppotelli G; Dryselius R; Masucci MG
FASEB J; 2012 Dec; 26(12):5060-70. PubMed ID: 22932395
[TBL] [Abstract][Full Text] [Related]
3. PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells.
Bheda A; Yue W; Gullapalli A; Shackelford J; Pagano JS
Leuk Lymphoma; 2011 Jul; 52(7):1336-47. PubMed ID: 21504384
[TBL] [Abstract][Full Text] [Related]
4. UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity.
Zhong J; Zhao M; Ma Y; Luo Q; Liu J; Wang J; Yuan X; Sang J; Huang C
Int J Mol Med; 2012 Aug; 30(2):430-6. PubMed ID: 22641175
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin dimers control the hydrolase activity of UCH-L3.
Setsuie R; Sakurai M; Sakaguchi Y; Wada K
Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
[TBL] [Abstract][Full Text] [Related]
6. NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression.
Wang R; Zhang M; Zhou W; Ly PT; Cai F; Song W
J Neurochem; 2011 Mar; 116(6):1160-70. PubMed ID: 21210816
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish.
Son OL; Kim HT; Ji MH; Yoo KW; Rhee M; Kim CH
Biochem Biophys Res Commun; 2003 Dec; 312(3):601-7. PubMed ID: 14680807
[TBL] [Abstract][Full Text] [Related]
8. TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.
Vietor I; Kurzbauer R; Brosch G; Huber LA
J Biol Chem; 2005 Dec; 280(48):39795-801. PubMed ID: 16204248
[TBL] [Abstract][Full Text] [Related]
9. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1.
Meray RK; Lansbury PT
J Biol Chem; 2007 Apr; 282(14):10567-75. PubMed ID: 17259170
[TBL] [Abstract][Full Text] [Related]
10. The evolutionarily conserved deubiquitinase UBH1/UCH-L1 augments DAF7/TGF-β signaling, inhibits dauer larva formation, and enhances lung tumorigenesis.
Nagata A; Itoh F; Sasho A; Sugita K; Suzuki R; Hinata H; Shimoda Y; Suzuki E; Maemoto Y; Inagawa T; Fujikawa Y; Ikeda E; Fujii C; Inoue H
J Biol Chem; 2020 Jul; 295(27):9105-9120. PubMed ID: 32371398
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction.
Bishop P; Rocca D; Henley JM
Biochem J; 2016 Aug; 473(16):2453-62. PubMed ID: 27515257
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) Promotes Hippocampus-Dependent Memory via Its Deubiquitinating Effect on TrkB.
Guo YY; Lu Y; Zheng Y; Chen XR; Dong JL; Yuan RR; Huang SH; Yu H; Wang Y; Chen ZY; Su B
J Neurosci; 2017 Jun; 37(25):5978-5995. PubMed ID: 28500221
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin C-terminal hydrolase UCH-L1 regulates B-cell proliferation and integrin activation.
Rolén U; Freda E; Xie J; Pfirrmann T; Frisan T; Masucci MG
J Cell Mol Med; 2009 Aug; 13(8B):1666-1678. PubMed ID: 20187292
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-Catenin Signaling Mediated-UCH-L1 Expression in Podocytes of Diabetic Nephropathy.
Zhang H; Luo W; Sun Y; Qiao Y; Zhang L; Zhao Z; Lv S
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571062
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin C-terminal hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation.
Henderson MJ; Vij N; Zeitlin PL
J Biol Chem; 2010 Apr; 285(15):11314-25. PubMed ID: 20147297
[TBL] [Abstract][Full Text] [Related]
16. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
[TBL] [Abstract][Full Text] [Related]
17. The potential role of ubiquitin c-terminal hydrolases in oncogenesis.
Fang Y; Fu D; Shen XZ
Biochim Biophys Acta; 2010 Aug; 1806(1):1-6. PubMed ID: 20302916
[TBL] [Abstract][Full Text] [Related]
18. The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes.
Zhang H; Sun Y; Hu R; Luo W; Mao X; Zhao Z; Chen Q; Zhang Z
Cell Signal; 2013 Jul; 25(7):1574-85. PubMed ID: 23567262
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin carboxyl terminal hydrolase L1 negatively regulates TNFalpha-mediated vascular smooth muscle cell proliferation via suppressing ERK activation.
Ichikawa T; Li J; Dong X; Potts JD; Tang DQ; Li DS; Cui T
Biochem Biophys Res Commun; 2010 Jan; 391(1):852-6. PubMed ID: 19945429
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
